Quantum Surgical, an innovative surgical robotics company expands its Scientific Advisory Board (SAB) with the appointment of two leading North American physicians.
The Quantum Surgical Scientific Advisory Board (SAB) is a multi-disciplinary board composed of international experts in the field of image-guided interventional oncology:
- Professor Luigi Solbiati (IT), Interventional Radiologist, pioneer of percutaneous liver ablation techniques, Professor of Radiology at Humanitas University (Rozzano – Milan),
- Professor Boris Guiu (FR), Interventional Radiologist, Head of the Department of Diagnostic and Interventional Radiology of Saint Eloi (Montpellier University Hospital),
- Professor David C. Madoff (US), Interventional Radiologist at Yale New Haven Hospital (Yale University)
- Professor Nishita Kothary (US), Interventional Radiologist at Stanford University MedicalCenter (Stanford)
- Professor Steven D. Colquhoun (US), Liver surgeon, specialized in robotic surgery at UC Davis Comprehensive Cancer Center (Sacramento),
Professor Guy Vallancien (FR), urology surgeon, and pioneer of laparoscopic and robotic surgery, is an honorary member of this scientific advisory board.
Quantum Surgical is therefore reinforcing its collaboration with clinical experts as part of its development projects to strengthen its strategy with regard to the European and American markets.
“We are highly honored and delighted to be able to put to good use all the precious advice provided by these internationally renowned physicians and be accompanied during the clinical development of our solution,” explains Bertin Nahum, CEO, and co-founder of Quantum Surgical.
Quantum Surgical in a few words
Co-founded in 2017 by Bertin Nahum, Quantum Surgical is an innovative Robotic Surgery Start-up company based in France’s Montpellier region that is aiming is to conceive an innovative solution; a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer. This platform combining robotics, image analytics, and artificial intelligence will allow more and more patients to benefit from safer interventional oncology procedures, especially in the case of early-stage liver cancers. The incidence of liver cancer in the population is, unfortunately, growing very rapidly. It is one of the most common cancers with more than 8000 new cases each year in France and 800 000 cases in the world
Further information is available on our website: https://quantumsurgical.com/
